204 related articles for article (PubMed ID: 20821036)
21. [Macular pathology as a cause of visual impairment?].
Matlach J; Nowak J; Pérez Tejón JM; Göbel W
Ophthalmologe; 2013 Aug; 110(8):761-5. PubMed ID: 23765371
[TBL] [Abstract][Full Text] [Related]
22. Patterns of visual loss associated with pituitary macroadenomas.
Poon A; McNeill P; Harper A; O'Day J
Aust N Z J Ophthalmol; 1995 May; 23(2):107-15. PubMed ID: 7546685
[TBL] [Abstract][Full Text] [Related]
23. Dynamics of visual improvement following chiasmal decompression. Quantitative pre- and postoperative observations.
Jakobsson KE; Petruson B; Lindblom B
Acta Ophthalmol Scand; 2002 Oct; 80(5):512-6. PubMed ID: 12390163
[TBL] [Abstract][Full Text] [Related]
24. Dichoptic stimulation improves detection of glaucoma with multifocal visual evoked potentials.
Arvind H; Klistorner A; Graham S; Grigg J; Goldberg I; Klistorner A; Billson FA
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4590-6. PubMed ID: 17898282
[TBL] [Abstract][Full Text] [Related]
25. [The importance of electrophysiological tests in early diagnosis of optic nerve dysfunction coexisting with pituitary adenomas--review and own experience].
Lachewicz E; Lubiński W
Klin Oczna; 2015; 117(1):50-5. PubMed ID: 26349160
[TBL] [Abstract][Full Text] [Related]
26. Effect of recording duration on the diagnostic performance of multifocal visual-evoked potentials in high-risk ocular hypertension and early glaucoma.
Fortune B; Zhang X; Hood DC; Demirel S; Patterson E; Jamil A; Mansberger SL; Cioffi GA; Johnson CA
J Glaucoma; 2008; 17(3):175-82. PubMed ID: 18414101
[TBL] [Abstract][Full Text] [Related]
27. The Chiasmal Compression Index: An Integrative Assessment Tool for Visual Disturbances in Patients with Pituitary Macroadenomas.
Avraham E; Azriel A; Melamed I; Alguayn F; Al Gawad Siag A; Aloni E; Sufaro Y
World Neurosurg; 2020 Nov; 143():e44-e50. PubMed ID: 32562903
[TBL] [Abstract][Full Text] [Related]
28. Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.
Laron M; Cheng H; Zhang B; Schiffman JS; Tang RA; Frishman LJ
Mult Scler; 2010 Apr; 16(4):412-26. PubMed ID: 20207786
[TBL] [Abstract][Full Text] [Related]
29. Segmented retinal layer analysis of chiasmal compressive optic neuropathy in pituitary adenoma patients.
Moon JS; Shin SY
Graefes Arch Clin Exp Ophthalmol; 2020 Feb; 258(2):419-425. PubMed ID: 31853626
[TBL] [Abstract][Full Text] [Related]
30. Detecting early to mild glaucomatous damage: a comparison of the multifocal VEP and automated perimetry.
Hood DC; Thienprasiddhi P; Greenstein VC; Winn BJ; Ohri N; Liebmann JM; Ritch R
Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):492-8. PubMed ID: 14744890
[TBL] [Abstract][Full Text] [Related]
31. Frequency doubling perimetry in patients with mild and moderate pituitary tumor-associated visual field defects detected by conventional perimetry.
Monteiro ML; Moura FC; Cunha LP
Arq Bras Oftalmol; 2007; 70(2):323-9. PubMed ID: 17589707
[TBL] [Abstract][Full Text] [Related]
32. Multifocal blue-on-yellow visual evoked potentials in early glaucoma.
Klistorner A; Graham SL; Martins A; Grigg JR; Arvind H; Kumar RS; James AC; Billson FA
Ophthalmology; 2007 Sep; 114(9):1613-21. PubMed ID: 17822971
[TBL] [Abstract][Full Text] [Related]
33. The Predictive Value of Suprasellar Extension for Visual Function Evaluation in Chinese Patients with Nonfunctioning Pituitary Adenoma with Optic Chiasm Compression.
Gan L; Ma J; Feng F; Wang Y; Cui J; Guo X; Zhang X; You H; Wang Z; Yin Z; Zhong Y; Xing B
World Neurosurg; 2018 Aug; 116():e960-e967. PubMed ID: 29857216
[TBL] [Abstract][Full Text] [Related]
34. [The extent of visual field damage in chiasmal lesions--contribution to the selection of methods for visual field examination].
Lesták J; Houst'ava L
Cesk Slov Oftalmol; 1995 Jul; 51(3):171-6. PubMed ID: 7656353
[TBL] [Abstract][Full Text] [Related]
35. The role of optical coherence tomography in the detection of pituitary adenoma.
Johansson C; Lindblom B
Acta Ophthalmol; 2009 Nov; 87(7):776-9. PubMed ID: 18771481
[TBL] [Abstract][Full Text] [Related]
36. The role of the multifocal visual evoked potential (mfVEP) latency in understanding optic nerve and retinal diseases.
Hood DC; Chen JY; Yang EB; Rodarte C; Wenick AS; Grippo TM; Odel JG; Ritch R
Trans Am Ophthalmol Soc; 2006; 104():71-7. PubMed ID: 17471327
[TBL] [Abstract][Full Text] [Related]
37. Identifying preperimetric functional loss in glaucoma: a blue-on-yellow multifocal visual evoked potentials study.
Arvind H; Graham S; Leaney J; Grigg J; Goldberg I; Billson F; Klistorner A
Ophthalmology; 2009 Jun; 116(6):1134-41. PubMed ID: 19395037
[TBL] [Abstract][Full Text] [Related]
38. [New insights into the pathogenesis of glaucomatous optic neuropathy and refinement of the objective assessment of its functional damage].
Nakamura M
Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):298-344; discussion 345-6. PubMed ID: 22568105
[TBL] [Abstract][Full Text] [Related]
39. [Assessment of compressive optic neuropathy in hipofizar tumors].
Predoi DV; Badiu C; Dărăban C; Stângu C; Dumitrache M
Oftalmologia; 2008; 52(4):110-7. PubMed ID: 19354173
[TBL] [Abstract][Full Text] [Related]
40. Visual Defects in Patients With Pituitary Adenomas: The Myth of Bitemporal Hemianopsia.
Lee IH; Miller NR; Zan E; Tavares F; Blitz AM; Sung H; Yousem DM; Boland MV
AJR Am J Roentgenol; 2015 Nov; 205(5):W512-8. PubMed ID: 26496573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
